19 research outputs found

    Genes down-regulated in RNase T2 mutant cells.

    No full text
    1<p>ATCC17978 locus tag; adjacent loci are highlighted in grey; loci associated with pili formation and motility are bolded.</p

    Motility of <i>A. baumannii</i> strains.

    No full text
    <p><b>Panel A.</b> Images displaying the motility properties of <i>A. baumannii</i> strains 98-37-09, 98-37-09 (pWH1266; vector), ACJ7, ACJ7 (pWH1266), and ACJ7 (pACJ02; RNase T2 complementation plasmid). <b>Panel B.</b> For each strain, the diameter across the largest portion of the resulting cell motility halo was measured in millimeters, averaged (n = 3) and plotted; the Wilcoxon rank sum test (NS: not significant, i.e. <i>p</i>≥0.05, or significant at <i>p</i><0.05) are shown above each pair of strain-specific data.</p

    Bacterial strains and plasmids used in this study.

    No full text
    1<p>Ampicillin (Amp); Kanamycin (Kan); Tetracycline (Tet), Resistant (r).</p>2<p>American Type Culture Collection (ATCC).</p

    Surface colonization properties of <i>A. baumannii</i> strains.

    No full text
    <p>Shown are images and corresponding quantified measures of solubilized crystal violet stained <i>A. baumannii</i> wildtype, ACJ7, and RNase T2 family complemented cells to polypropylene endotracheal tubes at 37°C (<b>Panels A</b> and <b>B</b>; n = 3/group), glass cover slips (25°C; <b>Panels C</b> and <b>D</b>; n = 3/group), and stainless steel disks (25°C; <b>Panels E</b> and <b>F</b>; and 37°C; <b>Panels G</b> and <b>H</b>; n = 5/group for these disks). Asterisks indicate statistically significant differences between wildtype, ACJ7, and complement strain adherence as determined by two-way Analysis of Variance (<i>p</i><0.05). Each data set is representative of at least two independent experiments.</p

    Polystyrene colonization.

    No full text
    <p><b>Panel A.</b> Representative images of <i>A. baumannii</i> strains ATCC17978 and 98-37-09 colonization of 24 well polystyrene microtiter plates as visualized by crystal violet staining after 48 h incubation at 37°C. <b>Panel B.</b> Representative images of <i>A. baumannii</i> strains ATCC17978, ACJ7, and 98-37-09 colonization of polystyrene tubes after 48 h incubation.</p

    Zinc Pyrithione Improves the Antibacterial Activity of Silver Sulfadiazine Ointment

    No full text
    ABSTRACT Pseudomonas aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus are commonly associated with biofilm-associated wound infections that are recalcitrant to conventional antibiotics. As an initial means to identify agents that may have a greater propensity to improve clearance of wound-associated bacterial pathogens, we screened a Food and Drug Administration-approved drug library for members that display bactericidal activity toward 72-h-established P. aeruginosa biofilms using an adenylate kinase reporter assay for bacterial cell death. A total of 34 compounds displayed antibiofilm activity. Among these, zinc pyrithione was also shown to reduce levels of A. baumannii and S. aureus biofilm-associated bacteria and exhibited an additive effect in combination with silver sulfadiazine, a leading topical therapeutic for wound site infections. The improved antimicrobial activity of zinc pyrithione and silver sulfadiazine was maintained in an ointment formulation and led to improved clearance of P. aeruginosa, A. baumannii, and S. aureus in a murine model of wound infection. Taken together, these results suggest that topical zinc pyrithione and silver sulfadiazine combination formulations may mitigate wound-associated bacterial infections and disease progression. IMPORTANCE Topical antimicrobial ointments ostensibly mitigate bacterial wound disease and reliance on systemic antibiotics. Yet studies have called into question the therapeutic benefits of several traditional topical antibacterials, accentuating the need for improved next-generation antimicrobial ointments. Yet the development of such agents consisting of a new chemical entity is a time-consuming and expensive proposition. Considering that drug combinations are a mainstay therapeutic strategy for the treatment of other therapeutic indications, one alternative approach is to improve the performance of conventional antimicrobial ointments by the addition of a well-characterized and FDA-approved agent. Here we report data that indicate that the antimicrobial properties of silver sulfadiazine ointments can be significantly improved by the addition of the antifungal zinc pyrithione, suggesting that such combinations may provide an improved therapeutic option for the topical treatment of wound infections
    corecore